FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| SKNV | 080105003 | 72934-1399 | 72934-1399-2 | Niacinamide; Ivermectin; Metronidazole; Brimonidine Tartrate | 4 g/100 mL; 1 g/100 mL; 1 g/100 mL; .25 g/100 mL | 2024-2 | valid | 2026-10-17 | |
| SKNV | 72934-1399 | 72934-1399-2 | Dazaveidaoxia | 171082 BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4% | 4 g/100 mL; 1 g/100 mL; 1 g/100 mL; .25 g/100 mL | 2024-2 | valid | 2026-09-18 | |
| SKNV | 080105003 | 72934-1399 | 72934-1399-2 | Niacinamide; Ivermectin; Metronidazole; Brimonidine Tartrate | 4 g/100 mL; 1 g/100 mL; 1 g/100 mL; .25 g/100 mL | 2024-1 | valid | 2026-10-17 | |
| SKNV | 080105003 | 72934-1399 | 72934-1399-2 | Niacinamide; Ivermectin; Metronidazole; Brimonidine Tartrate | 4 g/100 mL; 1 g/100 mL; 1 g/100 mL; .25 g/100 mL | 2023-2 | valid | 2026-10-17 |